Picoplatin
This is an old revision of this page, as edited by Fox (talk | contribs) at 19:32, December 29, 2007. It may differ significantly from current revision.
Picoplatin is an intravenous platinum-based chemotherapy drug that has been designed to overcome the problems normally associated with resistance in chemotherapy regimes using platinum compounds. It was developed by a Californian company, Poniard Pharmaceuticals, as a treatment for aggressive small cell lung cancer.